Results 201 to 210 of about 40,704 (273)

Additive interaction between CYP2C19AA gene polymorphism and Lp(a) on the prognosis of stroke patients. [PDF]

Am J Transl Res
Peng D, Pan X, Wei Y, Huang T, Zeng L, Gao C, Ban Y, Cui W, Meng X.   +8 more
europepmc   +1 more source

Advancing inclusive healthcare through PBPK modelling: predicting the impact of CYP genotypes and enzyme ontogenies on infant exposures of venlafaxine and its active metabolite O-desmethylvenlafaxine in lactation. [PDF]

J Pharmacokinet Pharmacodyn
Pan X, Rowland Yeo K.
europepmc   +1 more source

Investigating Real-World Clopidogrel Pharmacogenetics in Stroke Using a Bioresource Linked to Electronic Medical Records [PDF]

, 2017
Doney, Alex S. F., Flynn, Rob, MacDonald, Thomas M., Morant, Steve, Palmer, Colin N. A., Tornio, Aleksi, Velten, Elena   +6 more
core   +2 more sources

Exploring the relationship of platelet aggregation function with efficacy and safety outcomes following the administration of prasugrel and clopidogrel in patients with thrombotic stroke: a post hoc analysis of PRASTRO pooled studies. [PDF]

J Thromb Thrombolysis
Kimura K, Kamouchi M, Matsumaru Y, Kimura T, Katsuro R, Hosokawa J, Kitazono T.   +6 more
europepmc   +1 more source

<i>In vivo</i> effects of bempedoic acid on microdosed CYP probe drugs. [PDF]

Front Pharmacol
Stoll F, Amato S, Burhenne J, Blank A.
europepmc   +1 more source

Estimating the incidence of actionable drug-gene interactions in Japanese patients with major depressive disorder. [PDF]

Front Psychiatry
Hatano M, Ikeda M, Saito T, Miyata M, Iwata N, Yamada S.   +5 more
europepmc   +1 more source

The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real‐World Setting [PDF]

, 2017
Beitelshees, AL, Blake, KV, Cavallari, LH, Dressler, LG, Duarte, JD, Eichmeyer, JN, Elsey, A, Empey, PE, Franciosi, JP, Hicks, JK, Holmes, AM, Jeng, LJB, Johnson, JA, Lee, CR, Lima, JJ, Limdi, NA, Modlin, J, Obeng, AO, Peterson, JF, Petry, N, Pratt, VM., Skaar, TC, Tuteja, S, Voora, D, Wagner, M, Weitzel, KW, Wilke, RA   +26 more
core   +1 more source

Pharmacogenetic Evaluation of Hospitalized Patients Requiring Naloxone for Reversal of Acute Opioid Toxicity. [PDF]

Hosp Pharm
Grahl J, Mills M, Singh A, Oxencis C, Mohr A, Mancuso T, Teng BQ, Bajorunaite R, Carver T, Peppard WJ.   +9 more
europepmc   +1 more source

Implementing CYP2C19-guided clopidogrel therapy: a scoping review of pharmacogenomic testing services. [PDF]

Pharmacogenomics J
Patel TJ, Wehbe E, Hughes S, Patanwala AE, Kritharides L, Lal S, Patel S, Stocker SL.   +7 more
europepmc   +1 more source

Recommendations for Clinical CYP2C19 Genotyping Allele Selection: A Report of the Association for Molecular Pathology.

Journal of Molecular Diagnostics, 2018
V. Pratt, Andria L. Del Tredici, H. Hachad, Yuan Ji, L. Kalman, S. Scott, K. Weck   +6 more
semanticscholar   +1 more source